Cyclodextrins are a family of cyclic oligosaccharides composed of α - (1,4) - linked D - glucopyranose units. They have a truncated - cone - shaped structure with a hydrophobic cavity and a hydrophilic outer surface, which enables them to form inclusion complexes with a variety of guest molecules. This property has made cyclodextrins widely used in many fields, especially in pharmaceuticals, food, and cosmetics. Among the various types of cyclodextrins, Sulfobutyl Ether - β - cyclodextrin (SBE - β - CD) stands out due to its unique characteristics. As a supplier of Sulfobutyl Ether - β - cyclodextrin, I am well - positioned to discuss the differences between SBE - β - CD and other cyclodextrins.
1. Chemical Structure
The basic structure of cyclodextrins consists of 6, 7, or 8 glucose units, known as α - cyclodextrin (α - CD), β - cyclodextrin (β - CD), and γ - cyclodextrin (γ - CD) respectively. Their cavity sizes vary according to the number of glucose units: α - CD has the smallest cavity, followed by β - CD, and γ - CD has the largest one.
Sulfobutyl Ether - β - cyclodextrin is a derivative of β - cyclodextrin. In SBE - β - CD, some of the hydroxyl groups on β - cyclodextrin are substituted with sulfobutyl ether groups (-O-(CH₂)₄ - SO₃⁻Na⁺). The degree of substitution (DS), which represents the average number of substituted hydroxyl groups per glucose unit, can vary. Generally, the DS of SBE - β - CD ranges from 4 to 7. This chemical modification results in a negatively charged, hydrophilic derivative of β - cyclodextrin, significantly different from the unsubstituted β - CD and other non - modified cyclodextrins.
2. Solubility
One of the most significant differences between Sulfobutyl Ether - β - cyclodextrin and other cyclodextrins lies in solubility. α - CD, β - CD, and γ - CD have different solubility profiles in water. β - cyclodextrin, in particular, has relatively low water solubility (about 1.85 g/100 mL at 25°C), which limits its application in aqueous systems.
In contrast, SBE - β - CD is highly soluble in water. Its solubility can be as high as 500 g/L or more, depending on the degree of substitution. This high solubility is due to the introduction of the hydrophilic sulfobutyl ether groups. The negative charge on these groups increases the interaction between SBE - β - CD and water molecules through ion - dipole forces, facilitating its dissolution in water. This property makes SBE - β - CD more suitable for formulating aqueous - based products, such as injectable medications. You can find more information about Sulfobutyl Ether - β - cyclodextrin at Sulfobutyl Ether Bate Cyclodextrin.
3. Toxicity and Biocompatibility
The toxicity of cyclodextrins is an important consideration, especially in pharmaceutical applications. Non - modified cyclodextrins can have different levels of toxicity. For example, β - cyclodextrin can cause hemolysis and renal toxicity when used in high dosages. This is because β - CD can form inclusion complexes with cholesterol and other lipids in cell membranes, leading to membrane destabilization.
Sulfobutyl Ether - β - cyclodextrin, on the other hand, has much lower toxicity. The introduction of sulfobutyl ether groups changes the interaction between SBE - β - CD and cell membranes. It also has a higher affinity for drugs than for membrane components, reducing the risk of membrane damage. In addition, SBE - β - CD is rapidly excreted from the body through the kidneys, minimizing its accumulation and potential long - term toxic effects. This excellent biocompatibility makes it a preferred choice for parenteral drug delivery. For details about its safety profile, you can refer to Betadex Sulfobutyl Ether Sodium.
4. Complexation Ability
All cyclodextrins have the ability to form inclusion complexes with various guest molecules. However, the complexation ability and selectivity can vary. The size of the cyclodextrin cavity plays a crucial role in determining the types of guest molecules that can be included. For instance, α - CD is suitable for small guest molecules, while γ - CD can accommodate larger ones.
Sulfobutyl Ether - β - cyclodextrin has a unique complexation behavior. The sulfobutyl ether groups not only increase the solubility but also change the electronic environment of the cavity. This can enhance the affinity of SBE - β - CD for certain types of drugs, especially those with a positive charge or hydrophobic characteristics. The negative charge on the sulfobutyl ether groups can interact with positively charged drugs through electrostatic forces, in addition to the hydrophobic interactions within the cavity. This dual - mode interaction often leads to the formation of more stable inclusion complexes compared to non - modified β - cyclodextrin or other cyclodextrins, which can improve the solubility, stability, and bioavailability of drugs. To learn more about the complexation ability of SBE - β - CD, visit Betadex Sulfobutyl Ether Sodium Salt.
5. Stability
In terms of chemical and physical stability, cyclodextrins can have different properties. Non - modified cyclodextrins are relatively stable under normal conditions, but they may be affected by factors such as temperature, pH, and the presence of other chemicals.
Sulfobutyl Ether - β - cyclodextrin shows good stability over a wide range of pH values. The sulfobutyl ether groups can protect the cyclodextrin ring from hydrolysis and other chemical reactions. It also has better physical stability in solution, and the inclusion complexes formed with drugs are less likely to dissociate compared to those formed with non - substituted cyclodextrins. This stability is beneficial for the long - term storage and performance of formulations containing SBE - β - CD.
Applications
The differences in the properties mentioned above lead to different applications of Sulfobutyl Ether - β - cyclodextrin and other cyclodextrins. Non - modified cyclodextrins are commonly used in oral formulations, food products, and some cosmetic applications. For example, β - cyclodextrin can be used to encapsulate flavors and essential oils in the food industry to improve their stability and controlled release.
SBE - β - CD, due to its high solubility, low toxicity, strong complexation ability, and good stability, is widely used in parenteral drug delivery, such as injectable and intravenous formulations. It can solubilize poorly water - soluble drugs, reduce drug irritation, and improve drug bioavailability. In addition, it can also be used in ophthalmic formulations, nasal sprays, and topical preparations.
Contact for Purchase
If you are interested in the unique properties of Sulfobutyl Ether - β - cyclodextrin and considering its application in your products, we are here to assist you. As a reliable supplier of Sulfobutyl Ether - β - cyclodextrin, we can provide high - quality products and professional technical support. Please feel free to contact us for more information and start the procurement negotiation.
References
- Stella, V. J., & He, Q. (2008). Sulfobutylether - β - cyclodextrin: what does it do and what does it not do? Journal of Inclusion Phenomena and Macrocyclic Chemistry, 62(1 - 2), 3 - 10.
- Loftsson, T., & Duchêne, D. (2007). Cyclodextrins and their pharmaceutical applications. International Journal of Pharmaceutics, 329(1 - 2), 1 - 11.
- Del Valle, E. M. M. (2004). Cyclodextrins and their uses: a review. Process Biochemistry, 39(9), 1033 - 1046.
